Anthem BCBSLow ImpactAdministrative
[California] Lenalidomide is now available with end‑to‑end REMS support
Published May 3, 2026
AI Summary
Lenalidomide (a cancer medication) is now available with end-to-end REMS (Risk Evaluation and Mitigation Strategy) support in California. This provides streamlined access and safety monitoring for this high-risk medication used primarily in oncology.
Action Required
Oncology practices prescribing lenalidomide should contact Anthem California for details on the new REMS support program. Review current lenalidomide prescribing and billing workflows to determine if enhanced REMS support can improve patient access or reduce administrative burden.
Plan Types
All Plans
States
CA
Specialties
oncology, hematology